Cited by 264Central Venous Catheters and HemodialysisNeutropenia and Cancer InfectionsInfective Endocarditis Diagnosis and Management

Management of venous port systems in oncology: a review of current evidence

Open access
Vescia, S., Baumgärtner, A.K., Jacobs, V.R., Kiechle-Bahat, M., Rody, A., Loibl, S., Harbeck, N.·2008·Annals of Oncology

Abstract

Background Over the last decades, many changes have occurred in oncology with new chemotherapy combinations and more complex application schemes becoming available. Central venous catheters and implantable venous port systems have become widely used and have facilitated the problem of vascular access. However, important complications are associated with permanent central venous catheters.Material and methods This review summarizes evidence on venous port system use published in Medline up to February 2007. Moreover, recent guidelines for the prevention and management of catheter-related infections issued by the Infectious Diseases Society of America, the American College of Critical Care Medicine, the Society for Healthcare Epidemiology of America, the Center for Disease Control and Prevention, Atlanta, and the Infectious Diseases Working Party of the German Society of Hematology and Oncology are included.Results Sterile precautions are essential when implanting and accessing port systems. Infections must be treated with adequate antimicrobial therapy. Catheter-related thromboembolic complications were found at a rate of 12-64% in retrospective studies. Five current clinical trials investigated the effect of prophylactic anticoagulation with either low molecular weight heparin or warfarin in cancer patients with central venous devices. On the basis of these results, routine anticoagulation cannot be recommended.Conclusions This article reviews the current literature on long-term complications of venous port systems, focusing on infection and thrombosis. In addition, it summarizes the evidence regarding routine maintenance of port systems in follow-up care.

Integrity signals

Registry

Crossref · 10.1093/annonc/mdm272

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The access required for intravenous infusions involves invasive procedures that can be inconvenient and painful and a drain on the time and resources of patients, healthcare professionals, and the healthcare system.

    “The access required for intravenous infusions, the standard administration route for biologic drugs in oncology, involves invasive procedures that can be inconvenient and painful and a drain on the time and resources of patients, healthcare professionals (HCPs), and the healthcare system in general [2–4].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vescia, S., Baumgärtner, A. K., Jacobs, V. R., Kiechle-Bahat, M., Rody, A., Loibl, S., & Harbeck, N.
Affiliations
  • German Breast Group (DE)
  • TUM Klinikum (DE)
  • University Hospital Frankfurt (DE)
Corresponding author
Baumgärtner, A.K.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2008-01
Volume
19
Issue
1
Pages
9-15
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2150240326
Cited by
264
References
56
Citations by year
2026: 10 · 2025: 10 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 21 · 2017: 14 · 2016: 17 · 2015: 8 · 2014: 21 · 2013: 12 · 2012: 20
FWCI
3.20
Type
journal article
Language
en
Open access
Locations
  • Annals of Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Health Professions › Emergency Medical Services › Central Venous Catheters and Hemodialysis
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
Keywords
central venous catheters, catheter-related infection, catheter-related thrombosis, thromboprophylaxis, low molecular weight heparin, warfarin, port maintenance, infection prevention guidelines
MeSH terms
Anticoagulants, Antineoplastic Agents, Catheterization, Central Venous, Catheters, Indwelling, Clinical Trials as Topic, Equipment Contamination, Humans, Neoplasms, Thromboembolism, Fungemia, Bacteremia, Infection Control, Antibiotic Prophylaxis, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review